Esatoglu, Sinem Nihal http://orcid.org/0000-0001-5414-7305
Ozguler, Yesim http://orcid.org/0000-0002-2082-4715
Hatemi, Gulen http://orcid.org/0000-0002-1952-1135
Article History
Accepted: 6 November 2023
First Online: 23 November 2023
Declarations
:
: Sinem Nihal Esatoglu has received honorariums for presentations from UCB Pharma, Roche, Pfizer, and Merck Sharp Dohme. Yesim Ozguler has received honorariums for presentations from UCB Pharma, Novartis, and Pfizer. Prof Hatemi has received research grant, lecture fees and fees for serving on an advisory board from Celgene, receiving consulting fees from UCB Pharma, Bayer, Johnson & Johnson, lecture fees from Novartis, Abbvie, Amgen, and UCB Pharma.
: Sinem Nihal Esatoglu has received honorariums for presentations from UCB Pharma, Roche, Pfizer, and Merck Sharp Dohme. Yesim Ozguler has received honorariums for presentations from UCB Pharma, Novartis, and Pfizer. Prof Hatemi has received research grant, lecture fees, and fees for serving on an advisory board from Celgene; consulting fees from UCB Pharma, Bayer, and Johnson & Johnson; and lecture fees from Novartis, Abbvie, Amgen, and UCB Pharma.
: All reported studies/experiments with human or animal subjects performed by the authors have been previously published and complied with all applicable ethical standards (including the Helsinki declaration and its amendments, institutional/national research committee standards, and international/national/institutional guidelines).